AI주식인사이트AI Stock Insight
C

케어젠

214370KOSDAQ

45.8 / 100

Reference Date: 2026-09-08

Financial Score15.0 / 40
News Sentiment18.8 / 25
Momentum2.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Plunged 31.5% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Caregen develops and sells pharmaceuticals, health supplements, medical devices, and cosmetics based on biomimetic peptides and growth factor proteins, leveraging a large peptide library with over 860 patents. The company offers key products such as blood sugar regulators, muscle health supplements, and weight management solutions, and is expanding into new drug pipelines for conditions like macular degeneration, diabetes, and hair loss through global sales in 130 countries.

Number of Employees

201people

Average Salary

50.8M KRW

Score Calculation Basis

Detailed Financial Score

PER
109.98Industry Average 15.000.0Point

7.3x industry avg (risky)

PBR
11.43Industry Average 1.200.0Point

9.5x industry avg (risky)

ROE
9.23Industry Average 8.004.0Point

In line with industry avg

Debt Ratio
4.90Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20253.0 / 10 points
Revenue Growth Rate
0.5 / 3

Avg ▼3.8% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼27.8% (2-year basis)

ROE Trend
2.5 / 4

Avg ROE 13.9% (declining, 3yr)

Detailed News Sentiment

2 totalPositive 1Neutral 0Negative 1Average Sentiment Score 75

Detailed Momentum

52-week position1.0Point

Near 52w low (1%, downtrend)

Current 45,200Won52-week high 150,10052-week low 43,850
1-month return0.0Point

1m -31.52% (strong drop)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0
  • Neutral반기보고서 (2026.06)2026-08-14